WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'0601 Infant (under 12 months) mortality rate: 392
GDP / capita (US$): 2'6551 Child (under 5 years) mortality rate: 452

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 8'482  8'296  8'112  7'931  7'754  6'186  5'297  3'918 
Births 256  254  250  245  239  190  212  155 
Surviving infants 247  244  240  235  229  177  192  137 
Pop. less than 5 years 1'176  1'146  1'113  1'074  1'029  888  955  626 
Pop. less than 15 years 2'955  2'897  2'843  2'791  2'741  2'653  2'311  1'683 
Female 15-49 years 2'220  2'183  2'147  2'111  2'073  1'492  1'175  872 

Number of reported cases

(Click for retrospective incidence data for Tajikistan)
Diphtheria
ChartChart
  11  11 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  16  192  6'897 
Mumps
ChartChart
  1'530  1'518  1'441  428 
Pertussis
ChartChart
  56  13  935 
Polio*
ChartChart
 
Rubella
ChartChart
  111 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tajikistan)
Vaccine year result method % card seen                                                
BCG 2011  98  DHS   91  98  98  98  97  97  99 
DTP1 2011  98  DHS   91  97  99  98  96  98  98 
DTP3 2011  93  DHS   91  96  97  96  94  96  96 
DTP4          92  96 
IPV1         
HepB_BD          95  98  98  98  98 
HepB3 2011  93  DHS   91  96  97  96  94  96 
Hib3 2011  93  DHS   91  96  97  96  94  96 
JapEnc         
MCV1          97  98  92  95  98  98 
MCV2          94  98  92  97  96  31 
PCV1         
PCV3         
Pol3 2011  92  DHS   91  96  94  97  96  97  98 
Rota1          94 
RotaC          85 
Rubella1          98  92 
TT2plus         
PAB         
VAD1          97  99* 
YFV          98 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tajikistan)
BCG
ChartChart
  98  98  97  97  98 
DTP1
ChartChart
  98  98  96  98  88 
DTP3
ChartChart
  97  96  94  96  83 
HepB3
ChartChart
  97  96  94  96 
HepB_BD
ChartChart
  98  98  98  98 
Hib3
ChartChart
  97  96  94  96 
MCV1
ChartChart
  98  92  94  98  88 
MCV2
ChartChart
  98  92  97  96  59 
PCV3
ChartChart
 
Pol3
ChartChart
  94  97  96  97  86 
RotaC
ChartChart
 

Number of districts in the country 66  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 94
From 80 to 89% 6
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2-5 days; 6 years; Yes
DT 6 year; Yes
DTwP 16 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Pediatric birth; Yes
IPV 4 months; Yes From September 2017
MR 12 months, 6 years; Yes
OPV birth; 2, 3, 4, 12 months; Yes
Rotavirus 2, 3 months; Yes
Td 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2010-2015  2010-2015  2011-2015  2011-2015  2007-2010  2008-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 66  66  66  65  65  66 

System performance

Total Nº districts in country number 65  66  66  66  65  65  66 
Nº districts with DTP3 coverage >=80% number 65  66  66  66  65  65  60 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  91 
Nº districts with measles (MCV1) coverage >=95% number 65  60  59  59  46  63 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  91  89  89  71  97 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 31    22  34  41  19 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.